GE HealthCare announces CareIntellect for Oncology, harnessing AI to give clinicians an easy way to see the patient journey in a single view

GE HealthCare announces CareIntellect for Oncology, harnessing AI to give clinicians an easy way to see the patient journey in a single view

  • Application goes beyond data aggregation to help clinicians quickly see a longitudinal view of their patient’s history, spotlighting disease progression and helping to inform proactive interventions

  • Tampa General Hospital and UT Southwestern Medical Center to be early evaluators of CareIntellect for Oncology

  • Application is the first within GE HealthCare’s new CareIntellect offering of clinical and operational applications, built to reduce provider integration burden and increase adoption speed for new applications

CHICAGO, October 21, 2024–(BUSINESS WIRE)–GE HealthCare (Nasdaq: GEHC) today announced CareIntellect for Oncology, a new cloud-first application that brings together multi-modal patient data from disparate systems into a single view, using generative AI to summarize clinical notes and reports. The application also surfaces relevant data allowing care teams to quickly understand disease progression and flag potential deviations from the treatment plan to help the clinician determine potential next steps and inform proactive interventions. The application, which is planned to be available to customers in U.S. next year, will initially focus on prostate and breast cancer. It organizes structured and unstructured data (e.g., medical images, medical records, notes, and device readings), summarizes complex medical histories, supports treatment response assessments, helps assess clinical trial eligibility, and tracks adherence to treatment protocols in an easy-to-navigate view. This is the first application within GE HealthCare’s new CareIntellect offering of clinical and operational applications designed to help healthcare providers quickly and easily install new applications without having to take a costly and time-consuming product-by-product integration approach.

Today physicians spend a significant amount of time getting up to speed on a patient’s history and care status—for a new patient this can take hours. The process is time-consuming and frustrating for clinicians because they need to assess a large volume of unstructured and multi-modal information stored across various siloed systems in order to find the necessary information and determine the best course of treatment. It also puts a significant cognitive burden on the clinician to identify any deviation in adherence to the treatment plan that could signal an emerging issue. For many cancer patients, the treatment journey lasts years and involves numerous doctor visits, tests, and treatments across several care settings. The result is a complex care journey that is difficult and time-consuming for care teams to review and assess and can negatively impact the patient experience and standard of care. Matching patients to potentially suitable clinical trials is also painstaking work, with 80% of oncologists reporting that they feel overwhelmed by the amount of new research and clinical trial information that they need to keep up with.[ii]

link

Leave a Reply

Your email address will not be published. Required fields are marked *